Blog Tag: Immunotherapy

Cell and Gene Therapies for Cancer: Future Promises and Challenges

Featured speakers:

J. Joseph Melenhorst, Ph.D., University of Pennsylvania

Laurence J. N. Cooper, M.D., Ph.D., Ziopharm Oncology

Moderated by:

Sean Sanders, Ph.D., Science/AAAS

Anti-idiotype Antibodies: Monoclonal Therapeutic Discovery and Development

Anti-Idiotype Antibodies

The monoclonal antibody therapy market is rapidly expanding with all major pharmaceutical companies seeking approval of more antibody drug modalities each year. In addition, many of the blockbuster monoclonal therapeutics are nearing the end of their patents and the opportunity for biosimilars looms in the marketplace.

Quarterly Antibody Product and Data Update: Edition #1

Antibody Product Update

New Products and Antibody Validation

Recombinant Antibodies

Next Generation Targets for Immuno-Oncology

R&D Systems Immuno-Oncology Webinar with Anthony Person, PhD

Anthony Person, PhD, Manager in Bioassay Development at Bio-Techne
Scott Schachtele, PhD, Product Manager at Bio-Techne